SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-04-005236
Filing Date
2004-11-09
Accepted
2004-11-09 14:22:40
Documents
6
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. b52082tke10vq.htm 10-Q 359114
2 EX-10.1 SERVICES AGREEMENT DATED JULY 23, 2004 b52082tkexv10w1.htm EX-10.1 262294
3 EX-31.1 SECTION 302 CERTIFICATION OF CEO b52082tkexv31w1.htm EX-31.1 7618
4 EX-31.2 SECTION 302 CERTIFICATION OF CFO b52082tkexv31w2.htm EX-31.2 7618
5 EX-32.1 SECTION 906 CERTIFICATION OF CEO b52082tkexv32w1.htm EX-32.1 2919
6 EX-32.2 SECTION 906 CERTIFICATION OF CFO b52082tkexv32w2.htm EX-32.2 2921
  Complete submission text file 0000950135-04-005236.txt   644665
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21481 | Film No.: 041128887
SIC: 2836 Biological Products, (No Diagnostic Substances)